Donaldson Company 2Q Sales Rise, Boosted by Life Sciences Business

Dow Jones02-26

By Nicholas G. Miller

Donaldson Company reported higher second-quarter sales, boosted by growth in its life sciences business.

The company posted net income of $92.5 million, or 78 cents a share, down from $95.9 million, or 79 cents a share, the year prior.

Adjusted earnings were 83 cents a share. Analysts polled by FactSet expected 89 cents a share.

Sales rose 3% to $896.3 million. Wall Street expected $898.7 million.

Life sciences sales increased 16% as a result of strong new equipment sales in food and beverage and disk drive.

Industrial solutions sales rose 2.4%, while mobile solutions sales increased 1.6%. In both segments, pricing and currency translation offset volume declines.

The company lowered its fiscal 2026 adjusted earnings guidance to $3.93 to $4.01 a share, compared with its previous forecast of $3.95 to $4.11 a share.

Donaldson raised its life sciences sales growth guidance to 5% to 9%, above its previous outlook of 1% to 5%.

Analysts see fiscal 2026 adjusted earnings of $4.05 a share.

Write to Nicholas G. Miller at nicholas.miller@wsj.com.

(END) Dow Jones Newswires

February 26, 2026 06:23 ET (11:23 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614304898?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 19:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614304898","market":"hk","top_or_hot":-1,"title":"Donaldson Company 2Q Sales Rise, Boosted by Life Sciences Business","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Nicholas G. Miller \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Donaldson Company reported higher second-quarter sales, boosted by growth in its life sciences business. \n</p>\n<p>\n  The company posted net income of $92.5 million, or 78 cents a share, down from $95.9 million, or 79 cents a share, the year prior. \n</p>\n<p>\n  Adjusted earnings were 83 cents a share. Analysts polled by FactSet expected 89 cents a share. \n</p>\n<p>\n  Sales rose 3% to $896.3 million. Wall Street expected $898.7 million. \n</p>\n<p>\n  Life sciences sales increased 16% as a result of strong new equipment sales in food and beverage and disk drive. \n</p>\n<p>\n  Industrial solutions sales rose 2.4%, while mobile solutions sales increased 1.6%. In both segments, pricing and currency translation offset volume declines. \n</p>\n<p>\n  The company lowered its fiscal 2026 adjusted earnings guidance to $3.93 to $4.01 a share, compared with its previous forecast of $3.95 to $4.11 a share. \n</p>\n<p>\n  Donaldson raised its life sciences sales growth guidance to 5% to 9%, above its previous outlook of 1% to 5%. \n</p>\n<p>\n  Analysts see fiscal 2026 adjusted earnings of $4.05 a share. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 26, 2026 06:23 ET (11:23 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Donaldson Company 2Q Sales Rise, Boosted by Life Sciences Business</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDonaldson Company 2Q Sales Rise, Boosted by Life Sciences Business\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-26 19:23</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Nicholas G. Miller \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Donaldson Company reported higher second-quarter sales, boosted by growth in its life sciences business. \n</p>\n<p>\n  The company posted net income of $92.5 million, or 78 cents a share, down from $95.9 million, or 79 cents a share, the year prior. \n</p>\n<p>\n  Adjusted earnings were 83 cents a share. Analysts polled by FactSet expected 89 cents a share. \n</p>\n<p>\n  Sales rose 3% to $896.3 million. Wall Street expected $898.7 million. \n</p>\n<p>\n  Life sciences sales increased 16% as a result of strong new equipment sales in food and beverage and disk drive. \n</p>\n<p>\n  Industrial solutions sales rose 2.4%, while mobile solutions sales increased 1.6%. In both segments, pricing and currency translation offset volume declines. \n</p>\n<p>\n  The company lowered its fiscal 2026 adjusted earnings guidance to $3.93 to $4.01 a share, compared with its previous forecast of $3.95 to $4.11 a share. \n</p>\n<p>\n  Donaldson raised its life sciences sales growth guidance to 5% to 9%, above its previous outlook of 1% to 5%. \n</p>\n<p>\n  Analysts see fiscal 2026 adjusted earnings of $4.05 a share. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 26, 2026 06:23 ET (11:23 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DCI","symbol_name":"唐纳森","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2614304898","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2614304898","pubTimestamp":1772104980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Donaldson Company reported higher second-quarter sales, boosted by growth in its life sciences business.The company posted net income of $92.5 million, or 78 cents a share, down from $95.9 million, or 79 cents a share, the year prior.Adjusted earnings were 83 cents a share. Analysts polled by FactSet expected 89 cents a share.Sales rose 3% to $896.3 million. Wall Street expected $898.7 million.Life sciences sales increased 16% as a result of strong new equipment sales in food and beverage and disk drive.Industrial solutions sales rose 2.4%, while mobile solutions sales increased 1.6%. In both segments, pricing and currency translation offset volume declines.The company lowered its fiscal 2026 adjusted earnings guidance to $3.93 to $4.01 a share, compared with its previous forecast of $3.95 to $4.11 a share.Donaldson raised its life sciences sales growth guidance to 5% to 9%, above its previous outlook of 1% to 5%.Analysts see fiscal 2026 adjusted earnings of $4.05 a share.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"DCI":"唐纳森"},"translate_title":"唐纳森公司第二季度销售额在生命科学业务的推动下增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCI":1.5},"content_text":"By Nicholas G. Miller \n\n\n \n\n\n  Donaldson Company reported higher second-quarter sales, boosted by growth in its life sciences business. \n\n\n  The company posted net income of $92.5 million, or 78 cents a share, down from $95.9 million, or 79 cents a share, the year prior. \n\n\n  Adjusted earnings were 83 cents a share. Analysts polled by FactSet expected 89 cents a share. \n\n\n  Sales rose 3% to $896.3 million. Wall Street expected $898.7 million. \n\n\n  Life sciences sales increased 16% as a result of strong new equipment sales in food and beverage and disk drive. \n\n\n  Industrial solutions sales rose 2.4%, while mobile solutions sales increased 1.6%. In both segments, pricing and currency translation offset volume declines. \n\n\n  The company lowered its fiscal 2026 adjusted earnings guidance to $3.93 to $4.01 a share, compared with its previous forecast of $3.95 to $4.11 a share. \n\n\n  Donaldson raised its life sciences sales growth guidance to 5% to 9%, above its previous outlook of 1% to 5%. \n\n\n  Analysts see fiscal 2026 adjusted earnings of $4.05 a share. \n\n\n \n\n\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2026 06:23 ET (11:23 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614304898","isCrawlerRequest":true}